hydroxychloroquine has been researched along with Congenital Immunodeficiency Disease in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkan, G | 1 |
| Artac, H | 1 |
| Oz, SKT | 1 |
| Emiroglu, M | 1 |
| Li, GM | 1 |
| Liu, HM | 1 |
| Guan, WZ | 1 |
| Xu, H | 1 |
| Wu, BB | 1 |
| Feng, JY | 1 |
| Sun, L | 1 |
2 other studies available for hydroxychloroquine and Congenital Immunodeficiency Disease
| Article | Year |
|---|---|
Management of COVID-19 pneumonia in a child with NEMO deficiency.
Topics: Amides; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Serotherapy; Ectodermal Dysplasia; | 2021 |
A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus: A case report.
Topics: Adolescent; Antibodies, Antinuclear; Asian People; Class I Phosphatidylinositol 3-Kinases; Complemen | 2019 |